CD244 represents a new therapeutic target in head and neck squamous cell carcinoma

Agresta, L., Lehn, M., Lampe, K., Cantrell, R., Hennies, C., Szabo, S., Wise-Draper, T., Conforti, L., Hoebe, K. and Janssen, E. M.  CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.  Journal For Immunotherapy Of Cancer.  2020; 8(1), e000245.  doi: 10.1136/jitc-2019-000245

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.